Fiduciary Group LLC Sells 12,500 Shares of Express Scripts Holding Company (ESRX)
Fiduciary Group LLC cut its holdings in shares of Express Scripts Holding Company (NASDAQ:ESRX) by 39.6% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 19,033 shares of the company’s stock after selling 12,500 shares during the period. Fiduciary Group LLC’s holdings in Express Scripts were worth $1,205,000 as of its most recent SEC filing.
A number of other large investors have also modified their holdings of the business. Park National Corp OH grew its position in shares of Express Scripts by 0.3% during the second quarter. Park National Corp OH now owns 3,575 shares of the company’s stock worth $228,000 after buying an additional 11 shares in the last quarter. Parkside Financial Bank & Trust grew its position in shares of Express Scripts by 0.3% during the second quarter. Parkside Financial Bank & Trust now owns 8,634 shares of the company’s stock worth $551,000 after buying an additional 23 shares in the last quarter. Carroll Financial Associates Inc. grew its position in shares of Express Scripts by 1.0% during the second quarter. Carroll Financial Associates Inc. now owns 3,186 shares of the company’s stock worth $203,000 after buying an additional 30 shares in the last quarter. CAPROCK Group Inc. grew its position in shares of Express Scripts by 0.9% during the second quarter. CAPROCK Group Inc. now owns 3,675 shares of the company’s stock worth $235,000 after buying an additional 33 shares in the last quarter. Finally, Sandy Spring Bank grew its position in shares of Express Scripts by 0.6% during the second quarter. Sandy Spring Bank now owns 6,464 shares of the company’s stock worth $413,000 after buying an additional 37 shares in the last quarter. Institutional investors own 88.44% of the company’s stock.
A number of equities analysts have recently commented on the company. BidaskClub downgraded Express Scripts from a “sell” rating to a “strong sell” rating in a research report on Friday, August 4th. ValuEngine raised Express Scripts from a “hold” rating to a “buy” rating in a research report on Monday, October 2nd. Robert W. Baird boosted their price objective on Express Scripts from $57.00 to $59.00 and gave the stock a “neutral” rating in a research report on Wednesday, October 25th. Royal Bank Of Canada initiated coverage on Express Scripts in a report on Tuesday, September 19th. They issued a “sector perform” rating and a $68.00 price target for the company. Finally, Morgan Stanley upped their price target on Express Scripts from $52.00 to $57.00 and gave the company an “underweight” rating in a report on Thursday, August 10th. Seven equities research analysts have rated the stock with a sell rating, ten have assigned a hold rating, six have assigned a buy rating and one has issued a strong buy rating to the company. The company currently has a consensus rating of “Hold” and a consensus target price of $69.53.
Shares of Express Scripts Holding Company (NASDAQ:ESRX) opened at $62.86 on Thursday. Express Scripts Holding Company has a 52 week low of $55.80 and a 52 week high of $77.50. The company has a current ratio of 0.73, a quick ratio of 0.61 and a debt-to-equity ratio of 0.86. The company has a market capitalization of $34,797.96, a P/E ratio of 8.98, a PEG ratio of 0.91 and a beta of 0.88.
Express Scripts (NASDAQ:ESRX) last released its quarterly earnings results on Tuesday, October 24th. The company reported $1.90 EPS for the quarter, hitting the Thomson Reuters’ consensus estimate of $1.90. The business had revenue of $24.68 billion during the quarter, compared to analysts’ expectations of $25.68 billion. Express Scripts had a return on equity of 25.46% and a net margin of 3.64%. The company’s quarterly revenue was down 2.9% compared to the same quarter last year. During the same quarter in the prior year, the business earned $1.74 earnings per share. research analysts forecast that Express Scripts Holding Company will post 7.01 EPS for the current fiscal year.
In other Express Scripts news, VP Phyllis S. Anderson sold 578 shares of the stock in a transaction on Friday, September 8th. The stock was sold at an average price of $63.13, for a total value of $36,489.14. Following the completion of the transaction, the vice president now owns 10,530 shares in the company, valued at $664,758.90. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Woodrow A. Myers, Jr. sold 3,900 shares of the stock in a transaction on Monday, September 11th. The stock was sold at an average price of $63.93, for a total value of $249,327.00. Following the completion of the transaction, the director now owns 11,500 shares of the company’s stock, valued at approximately $735,195. The disclosure for this sale can be found here. Insiders sold 5,121 shares of company stock valued at $325,920 in the last quarter. 0.68% of the stock is currently owned by company insiders.
About Express Scripts
Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM).
Want to see what other hedge funds are holding ESRX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Express Scripts Holding Company (NASDAQ:ESRX).
Receive News & Ratings for Express Scripts Holding Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts Holding Company and related companies with MarketBeat.com's FREE daily email newsletter.